Alcon Inc. (ALC)
NYSE
Closed
Aug 24, 2026
Day's Range
73.2152 wk Range
61.84Overview - ALC - Alcon Inc.
Key Statistics
Valuation
Enterprise Value
39.43B
P/E (Trailing)
‪56.20‬
P/E (Forward)
‪18.52‬
PEG Ratio
‪-1.24‬
Price / Sales (TTM)
‪3.27‬
Price / Book
‪1.64‬
EV / EBITDA
‪16.40‬
Profitability
Gross Margin
‪56.35%‬
Profit Margin
‪5.92%‬
Operating Margin
‪14.63%‬
Return on Assets
‪2.79%‬
Return on Equity
‪2.94%‬
Ownership
Shares Outstanding
487.70M
Float
481.82M
Held by Insiders
‪0.19%‬
Held by Institutions
‪66.09%‬
Price stats
Beta
‪0.69‬
50-Day Avg
‪69.15‬
200-Day Avg
‪74.65‬
Dividends
Payout Ratio
‪27.03%‬
Frequency
Annual
Analyst Consensus
26 analysts
Average price target
‪$ 85.24‬Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - ALC - Alcon Inc.
Peers - ALC - Alcon Inc.
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on NYSE.
Profile Summary - ALC - Alcon Inc.
About
Alcon Inc. is a leading global vision care company specializing in the development, manufacture, and marketing of surgical equipment, devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. Originally founded in 1945 and headquartered in Geneva, Switzerland, it…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
